Medavail Holdings Inc

MedAvail Holdings, Inc. is a technology-enabled pharmacy company, which engages in the development and commercialization of a self-service pharmacy, mobile application, kiosk, and drive-thru solution. It operates through the Retail Pharmacy Services and Pharmacy Technology segments. The Retail Pharmacy Services segment comprises the MedAvail Pharmacy Inc. and does business under the trade name SpotRx Pharmacy. The Pharmacy Technology segment represents MedAvail Technologies Inc. that sells the system including MedCenter prescription dispensing kiosk, software, integration, and maintenance services. The company was founded on April 11, 2007 and is headquartered in Mississauga, Canada.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q4 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

MedAvail Holdings, Inc. is a pharmacy technology and services company, which engages in the development and commercialization of a self-service pharmacy, mobile application, and kiosk. It operates through the Retail Pharmacy Services and Pharmacy Technology segments. The Retail Pharmacy Services segment includes MedAvail Pharmacy Inc. and does business under the trade name SpotRx Pharmacy. The Pharmacy Technology segment represents MedAvail Technologies Inc. that sells the system including MedCenter prescription dispensing kiosk, software, integration, and maintenance services. The company was founded on April 11, 2007 and is headquartered in Phoenix, AZ.

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company, today announced that the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at 1:20 p.m. ET. Interested parties can access a live webcast of the presentation directly by following this link. An archived w

MedAvail to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

MedAvail Holdings, Inc. (NASDAQ:MDVL ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Caroline Paul – Investor Relations Mark Doerr – Chief Executive Officer Ramona Seabaugh – Chief Financial Officer Conference Call Participants Charles Rhyee – Cowen Brooks O'Neil – Lake Street Capital Markets Operator Good afternoon, and thank you for attending today's MedAvail Second Quarter 2022 Earnings Call. My name is Austin, and I will be your operator for today.

MedAvail Holdings, Inc.'s (MDVL) CEO Mark Doerr on Q2 2022 Results - Earnings Call Transcript

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today reported financial results for the three months ended June 30, 2022. “We continued to execute on our strategic initiatives in the second quarter and are pleased to be introducing our full year revenue guidance. Our strong financial results are a testament to our focus on expanding our retail pharmacy and technology footprint, increasing utilization, a

MedAvail Reports Second Quarter 2022 Financial Results

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today announced it will report financial results for the second quarter of 2022 on Thursday, August 11, 2022, after market close. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the “Investor Relations” section of MedAvail's we

MedAvail to Report 2022 Second Quarter Financial Results on August 11, 2022

Catalyst Biosciences

Geovax Labs

Rhythm Pharmaceuticals

View

Penny stocks are red hot right now if you know where to… The post 5 Penny Stocks To Watch With High Short Interest, Are They A Buy Now? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

5 Penny Stocks To Watch With High Short Interest, Are They A Buy Now?

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--(Nasdaq: MDVL)— MedAvail Holdings, Inc. (“MedAvail”), a technology-enabled retail pharmacy company, today announced that the company will be participating in the following virtual investor conferences. Lytham Partners Summer 2022 Investor Conference Tuesday, June 21, 2022 to Wednesday, June 22, 2022 Presentation available beginning on June 21, 2022, at 9:00 a.m. Eastern Time Cowen 7th Annual FutureHealth Conference Fireside chat on Wednesday, Jun

MedAvail to Participate in Upcoming Investor Conferences

Here is how MedAvail Holdings, Inc. (MDVL) and Mirum Pharmaceuticals, Inc. (MIRM) have performed compared to their sector so far this year.

Is MedAvail (MDVL) Outperforming Other Medical Stocks This Year?

Eliem Therapeutics

Veru

Vertex Energy

Camping World Hlds

Short squeeze stocks are once again in focus this week as the bears continue to run wild in the stock market. The post Short Squeeze Stocks: VTNR, VERU and 3 Others Experts Think Are Ready to Pop appeared first on InvestorPlace.

Short Squeeze Stocks: VTNR, VERU and 3 Others Experts Think Are Ready to Pop

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.

5 Short Squeeze Candidates To Watch This Week: Vertex Energy Tops List, Medavail Holdings And Camping World Remain Elevated

MedAvail Holdings, Inc. (NASDAQ:MDVL ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Caroline Paul – Investor Relations Mark Doerr – Chief Executive Officer Ramona Seabaugh – Chief Financial Officer Conference Call Participants Charles Rhyee – Cowen Operator Hello, and a warm welcome to the MedAvail 2022 First Quarter Earnings Conference Call. My name is Lisa, and I will be your operator today.

MedAvail Holdings' (MDVL) CEO Mark Doerr on Q1 2022 Results - Earnings Call Transcript

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today reported financial results for the three months ended March 31, 2022. “I am proud of our team's strong start to the year. We delivered robust sales growth in the first quarter and achieved a milestone in our Pharmacy Technology business with the completion of our integration with Epic,” said Mark Doerr, Chief Executive Officer of MedAvail. “There is c

MedAvail Reports First Quarter 2022 Financial Results

Blue Apron

PAVmed

Short squeeze penny stocks to watch this week. The post 3 Short Squeeze Penny Stocks To Buy For Under $5 This Week￼ appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Short Squeeze Penny Stocks To Buy For Under $5 This Week￼

Short squeeze penny stocks to watch this week. The post 3 Short Squeeze Penny Stocks To Buy For Under $5 This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Short Squeeze Penny Stocks To Buy For Under $5 This Week

Harbor Custom Development, Inc.

Redbox Entertainment

Lixte Biotech

Short squeeze stocks are in focus today following another bearish week for the markets. Here are Fintel's top short squeeze candidates.

Short Squeeze Stocks: RDBX, MDVL and 3 Others Experts Think Are Ready to Pop

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today announced it will report financial results for the first quarter of 2022 on Thursday, May 12, 2022, after market close. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the “Investor Relations” section of MedAvail's websit

MedAvail to Report 2022 First Quarter Financial Results on May 12, 2022

CYNGN

Nordic American Tankers

Check these 3 penny stocks out that are climbing right now The post Hot Penny Stocks to Buy Right Now? 3 That Are Climbing Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Hot Penny Stocks to Buy Right Now? 3 That Are Climbing Today

Baosheng Media Group Holdings

Leap Therapeutics

Check these three penny stocks out for your watchlist right now The post Check These 3 Penny Stocks Out For Your Watchlist Right in Late-April  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Check These 3 Penny Stocks Out For Your Watchlist Right in Late-April

Camber Energy

CTI BioPharma

Didi Global

Imperial Petroleum

UP Fintech Holding

22nd Century Group

Penny stocks with unusual options activity today. Are they on your watch list right now?

7 Top Penny Stocks To Watch With Unusual Options Activity In April 2022

MedAvail Holdings, Inc. (MDVL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MedAvail Holdings, Inc. (MDVL) Moves to Buy: Rationale Behind the Upgrade

Aterian

Biofrontera

Lyra Therapeutics

ENDRA Life Sciences

We're diving into the top penny stocks for today in our market update for Friday with all the latest news that's moving shares! The post Top Penny Stocks Today: Why ATER, BFRI, NDRA, MDVL and LYRA Stocks Are Soaring Friday appeared first on InvestorPlace.

Top Penny Stocks Today: Why ATER, BFRI, NDRA, MDVL and LYRA Stocks Are Soaring Friday

SeaChange International

Here's what you need to know about trading penny stocks on April 8th The post Trading Penny Stocks on April 8th? What to Know on Friday  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Trading Penny Stocks on April 8th? What to Know on Friday

Arlington Asset Investment

Recruiter.com Group

US crude oil futures traded lower on Thursday. Investors, meanwhile, focused on some notable insider trades.

Executives Buy Over $1.5M Of 4 Penny Stocks

HTG Molecular Diagnostics

Momentus

Here's what you need to know about trading penny stocks on April 7th The post Trading Penny Stocks on April 7th? Fed News Causes Market Movement appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Trading Penny Stocks on April 7th? Fed News Causes Market Movement

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--(Nasdaq: MDVL) — MedAvail Holdings, Inc. (“MedAvail”), a technology-enabled retail pharmacy company, today announced the first closing of a private placement for the sale of approximately 37.6 million shares of common stock at an offering price of $1.0625 per share, together with the issuance of warrants to purchase approximately 18.8 million shares of common stock. The first closing of the private placement resulted in gross proceeds to MedAvail

MedAvail Announces Closing of Private Placement

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company, today announced it has entered into a definitive securities purchase agreement for the sale of common stock and warrants to purchase common stock in a private placement with certain institutional and other accredited investors for gross proceeds to MedAvail of $50 million, before deducting placement agent commissions and other offering expenses. Pur

MedAvail Announces Pricing of $50 Million Private Placement

News for Medavail Holdings Inc Stock (MDVL)